Nurse Practitioner, Family · Slidell, LA
NPI
1205333622
Since 2018
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
1850 Gause Blvd E Ste 101
Slidell, LA, 70461
Phone (985) 639-3777
Groups this clinician bills Medicare through
Medicare paid, 2024
$14K
308 services
Medicare patients, 2024
177
Average age 72
Drug cost, 2024
$3.4M
3,575 prescriptions
Company payments, 2025
$154K
From 22 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rebecca B Ezell was code 99213 (office e&m - established), 195 times for 133 patients. In total Rebecca B Ezell billed 308 services in 8 codes, and Medicare paid $14K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-04-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 195 | 133 | $37.83 | $7,377 |
| 99214 Office E&M - Established | Office | 86 | 70 | $57.36 | $4,933 |
By year: 2022 $18K for 374 services; 2023 $13K for 311 services; 2024 $14K for 308 services.
Medicare prescription drug claims, 2024
In 2024, the drug Rebecca B Ezell prescribed most often to Medicare patients was Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter), with 603 prescriptions and refills. In total Rebecca B Ezell wrote 3,575 Medicare prescriptions that cost $3.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 603 | 1,071 | 173 | $677K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 505 | 633 | 203 | $19K |
| Prednisone Generic | 417 | 485 | 241 | $1,493 |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 248 | 338 | 83 | $210K |
| Montelukast Sodium Generic | 174 | 425 | 55 | $1,393 |
| Nucala Mepolizumab | 157 | 157 | 20 | $577K |
| Breo Ellipta Fluticasone/Vilanterol | 105 | 148 | 27 | $57K |
| Fasenra Pen Benralizumab | 87 | 148 | 17 | $461K |
| Azithromycin Generic | 86 | 106 | 55 | $633 |
| Fluticasone Propionate Generic | 84 | 166 | 32 | $1,420 |
| Dupixent Pen Dupilumab | 80 | 80 | 13 | $292K |
| Symbicort Budesonide/Formoterol Fumarate | 74 | 94 | 22 | $21K |
| Tezspire Tezepelumab-Ekko | 74 | 74 | Under 11 | $309K |
| Advair Hfa Fluticasone Propion/Salmeterol | 60 | 80 | 12 | $30K |
| Ventolin Hfa Albuterol Sulfate | 52 | 65 | 27 | $4,064 |
Brand drugs: 2,137 claims; generic drugs: 1,438 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Rebecca B Ezell $154K ($154K in general payments such as food, travel and fees) from 22 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $86K.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 197 | $86K |
| Regeneron Healthcare Solutions, Inc. REGN | 80 | $33K |
| Genzyme Corporation SNY | 51 | $28K |
| GlaxoSmithKline, LLC. GSK | 38 | $4,507 |
| Regeneron Pharmaceuticals, Inc. REGN | 2 | $1,392 |
| Grifols USA, LLC | 8 | $326 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $147 |
| United Therapeutics Corporation UTHR | 6 | $142 |
| Inspire Medical Systems, Inc. INSP | 2 | $103 |
| Electromed, Inc. ELMD | 11 | $93.13 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.